Dakota Biotech

Oragenics is biopharmaceutical company. Its aim is to develop products through human proof-of-concept prior to partnering with major pharmaceutical, biotechnology or health care product firms for advanced clinical development and commercialization. It has developed a number of products, including replacement therapy, which is a single, painless topical treatment that offers protection from tooth decay; Mutacin 1140 is an antibiotic with activity against Gram-positive bacteria; oral probiotic technology, which employs naturally occurring beneficial bacteria to promote dental and periodontal health; in vivo-induced antigen technology, which provides a method for identification of new targets for use in the diagnosis and prevention of infectious diseases; and change mediated antigen technology, which identifies targets for diagnosis and treatment of cancers and other diseases in humans and other living organisms, including plants. Oragenics is headquartered in Alachua, Fla. It trades on the American Stock Exchange under the symbol ONI.

Innovative Research of America, based in Sarasota, FL, has been a leader in drug delivery technology for over thirty years, specializing in Time Release Hormone and Drug Pellets designed for biomedical research. Their advanced Matrix-Driven Delivery (MDD) Pellet System offers a reliable alternative to traditional injectable methods, allowing for continuous, controlled release of active products in laboratory animals. The company's innovative approach addresses the challenges of inconsistent drug administration, empowering researchers to standardize and reproduce their results effectively. Recognized for its effectiveness and safety, Innovative Research of America's pellet delivery system has been documented in scientific literature across various research disciplines. Generated from the website

Quorum Innovations is a Sarasota-based biopharmaceutical company that specializes in the discovery and development of human microbiome therapeutics. The company's primary focus is on advancing innovative treatments that harness the potential of the human microbiome to improve health and well-being. Generated from their website's infomation